[Skip to Navigation]
Sign In

April 2023 - January 1929

Decade

Year

Issue

May 2023, Vol 141, No. 5, Pages 420-500

Editorial

JAMA Ophthalmology—The Year in Review, 2022: Continued Evolution for Readers, Authors, and Editors

Abstract Full Text
free access
JAMA Ophthalmol. 2023;141(5):421-422. doi:10.1001/jamaophthalmol.2023.0587
Original Investigation

Pulsed Oral Azithromycin vs 6-Week Oral Doxycycline for Moderate to Severe Meibomian Gland Dysfunction: A Randomized Clinical Trial

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):423-429. doi:10.1001/jamaophthalmol.2023.0302

This randomized clinical trial attempts to determine if the adverse effects of a 3-week course of oral azithromycin were equivalent to the adverse effects of a 6-week course of oral doxycycline.

Epidemiologic Pattern and Injury Mechanism of Intimate Partner Violence–Related Ocular Trauma in the US

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):431-439. doi:10.1001/jamaophthalmol.2023.0578

This cross-sectional study investigates the epidemiological pattern of intimate partner violence–related ocular injury in adults in the US.

Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data

Abstract Full Text
free access has audio
JAMA Ophthalmol. 2023;141(5):441-447. doi:10.1001/jamaophthalmol.2023.0610

This cohort study examines the incidence of retinal vascular occlusion in individuals after receiving the mRNA COVID-19 vaccine.

Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):449-457. doi:10.1001/jamaophthalmol.2023.0706

This genetic association study investigates the genetic risk factors for central serous chorioretinopathy and their association with age-related macular degeneration.

Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial

Abstract Full Text
open access
JAMA Ophthalmol. 2023;141(5):459-466. doi:10.1001/jamaophthalmol.2023.0709

This randomized clinical trial investigates the effectiveness of a water-free cyclosporine eye drop, 0.1%, in the treatment of dry eye disease.

Association Between Social Determinants of Health and Examination-Based Vision Loss vs Self-reported Vision Measures

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):468-476. doi:10.1001/jamaophthalmol.2023.0723

This study attempts to identify associations between social determinants of health and evaluated vision impairment and assesses whether these associations hold when examining self-reported vision loss.

Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):479-485. doi:10.1001/jamaophthalmol.2023.0809

This cohort study investigates how changes in the incidence of retinopathy of prematurity have varied across subpopulations and locations in the US from 2003 to 2019.

Brief Report

Association of Gaps in Health Insurance Coverage With Unmet Needs for Vision Care Among Adults in Ohio

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):488-492. doi:10.1001/jamaophthalmol.2023.0847

This cross-sectional study examines Medicaid survey data to determine type of health insurance coverage, including its absence, and its association with the risk of vision care needs not being met in the past year.

Invited Commentary

Evaluating the Evidence for Treatment of Meibomian Gland Dysfunction With Oral Antibiotics

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):429-430. doi:10.1001/jamaophthalmol.2023.0320

Intimate Partner Violence and the Role of Ophthalmology

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):439-440. doi:10.1001/jamaophthalmol.2023.0580

No Red Flags for Risk of Retinal Vascular Occlusion After mRNA COVID-19 Vaccination

Abstract Full Text
free access
JAMA Ophthalmol. 2023;141(5):447-448. doi:10.1001/jamaophthalmol.2023.0925

What Can We Learn From the Surprising Insight Into the Genetic Background of Age-Related Macular Degeneration and Central Serous Chorioretinopathy?

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):457-458. doi:10.1001/jamaophthalmol.2023.0927

Comparison of Water-Free Commercially Available Cyclosporine Ophthalmic Preparations—Different, but the Same

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):466-467. doi:10.1001/jamaophthalmol.2023.0850

A Vision for Addressing Social Needs and Social Determinants of Health

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):477-478. doi:10.1001/jamaophthalmol.2023.0924

Nationwide Increase in the Incidence of Retinopathy of Prematurity in the US—A Growing Problem?

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):486-487. doi:10.1001/jamaophthalmol.2023.0926

Unmet Needs in Vision Care Among Vulnerable Patients

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):492-493. doi:10.1001/jamaophthalmol.2023.0956

Potential Rare Danger of Presumably Benign Artificial Tears

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):497-498. doi:10.1001/jamaophthalmol.2023.1114
JAMA Ophthalmology Clinical Challenge

Blurred Vision After a Kidney Transplant

Abstract Full Text
has active quiz
JAMA Ophthalmol. 2023;141(5):494-495. doi:10.1001/jamaophthalmol.2023.0707

A patient with cytomegalovirus viremia who underwent kidney transplant developed floaters in both eyes that did not improve after painful intravitreal injections of foscarnet and ganciclovir. What would you do next?

Observation

Multidrug-Resistant Pseudomonas aeruginosa Keratitis Associated With Artificial Tear Use

Abstract Full Text
JAMA Ophthalmol. 2023;141(5):499-500. doi:10.1001/jamaophthalmol.2023.1109

This case report describes severe multidrug-resistant Pseudomonas aeruginosa keratitis in a 72-year-old man after EzriCare artificial tear use.

Ophthalmic Images

Pseudomonas aeruginosa Corneal Ulcer Associated With Artificial Tears Eye Drops

Abstract Full Text
has active quiz
JAMA Ophthalmol. 2023;141(5):496. doi:10.1001/jamaophthalmol.2023.1105

This case report describes vision loss in a 72-year-old woman following use of EzriCare eye drops.

Subretinal Deposits Associated With Type 1 Cryoglobulinemia

Abstract Full Text
online only has active quiz
JAMA Ophthalmol. 2023;141(5):e230082. doi:10.1001/jamaophthalmol.2023.0082

This case report describes a female patient aged 30 years who presented with subretinal deposits and blurry vision in the setting of type 1 cryoglobulinemia.

Intravitreal Glioma in a Boy Aged 7 Years

Abstract Full Text
online only has active quiz
JAMA Ophthalmol. 2023;141(5):e230083. doi:10.1001/jamaophthalmol.2023.0083

This case report discusses a diagnosis of intravitreal glioma in a boy aged 7 years with neurofibromatosis type 1.

Subconjunctival Thelazia in a Chinese Woman Aged 49 Years

Abstract Full Text
online only has active quiz has multimedia
JAMA Ophthalmol. 2023;141(5):e230404. doi:10.1001/jamaophthalmol.2023.0404

This case report describes a diagnosis of subconjunctival Thelazia callipaeda in a 49-year-old Chinese woman who presented with pruritis and a crawling sensation of the left eye for 1 week.

Double Optic Disc Pit With Retinal Pigmentation in a Woman With High Myopia

Abstract Full Text
online only has active quiz
JAMA Ophthalmol. 2023;141(5):e230405. doi:10.1001/jamaophthalmol.2023.0405

This case report discusses a diagnosis of 2 optic disc pits in an otherwise asymptomatic woman with high myopia.

Peer Reviewers List

JAMA Ophthalmology Peer Reviewers in 2022

Abstract Full Text
free access online only
JAMA Ophthalmol. 2023;141(5):e230292. doi:10.1001/jamaophthalmol.2023.0292
JAMA Ophthalmology Masthead

JAMA Ophthalmology

Abstract Full Text
free access
JAMA Ophthalmol. 2023;141(5):420. doi:10.1001/jamaophthalmol.2022.4105
×